Skip to main navigation Skip to search Skip to main content

Early Disease Activity or Clinical Response as Predictors of Long-Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis

  • D. van der Heijde
  • , A. Deodhar
  • , R. Fleischmann
  • , P. J. Mease
  • , M. Rudwaleit
  • , T. Nurminen
  • , O. Davies

Research output: Contribution to journal › Article › peer-review

18   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Early Disease Activity or Clinical Response as Predictors of Long-Term Outcomes With Certolizumab Pegol in Axial Spondyloarthritis or Psoriatic Arthritis'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology